Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2022-10-24
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypotheses on which this study is based are; H1: Tele-assessment and face-to-face assessment results of the ICARS differ in patients with ataxic MS.
H2: Tele-assessment and face-to-face assessment results of SARA differ in patients with Ataxic MS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tele-Assessment and Face-to-Face Evaluation of Functional Gait Assessment in Multiple Sclerosis
NCT04932616
Tele-Assessment and Face-to-Face Evaluation of Balance in MS
NCT04743284
Investigation of the Effects of Technology Supported Different Physiotherapy Approaches on Patients With Multiple Sclerosis
NCT04891341
Body Awareness, Trunk Stability, and Arm Function in MS
NCT07151534
Motor Imagery Training in Persons With Multiple Sclerosis
NCT02781142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ataxic multiple sclerosis
In the study, those aged between 18-50 years, diagnosed with MS by a neurologist, Expanded Disability Status Scale (EDSS) score between 3-5, EDSS pyramidal system score ≤ 3 and cerebellar functional system score ≥ 1, patients who have been clinically stable for the last 3 months and have agreed to participate in the study will be included.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being diagnosed with MS by a neurologist
* Expanded Disability Status Scale (EDSS) score between 3-5
* EDSS pyramidal system score ≤ 3 and cerebellar functional system score ≥ 1
* Being clinically stable for the last 3 months
* agree to participate in the study
Exclusion Criteria
* Having a history of attacks in the last 3 months
* having peripheral vestibular complaints
* being mentally affected (Montreal Cognitive Rating Scale Score \< 21)
* severe spasticity (Modified Ashworth Scale \> 3)
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Güngör Beyza ÖZVAR
MSc physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muhammed Kılınç, PhD
Role: STUDY_DIRECTOR
Hacettepe University
Ender Ayvat, PhD
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Fatma Ayvat, PhD
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Tele-Assessment
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.